Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Cicatrising Conjunctivitis_Bernauer, Dart, Elder_1997

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
4.89 Mб
Скачать

..............................

Developments in

Ophthalmology

Vol. 28

..............................

Cicatrising Conjunctivitis

Including a Foreword by John Forrester, Aberdeen

Volume Editors

W. Bernauer, Zu¨ rich

 

J.K. Dart, London

 

M.J. Elder, Christchurch

 

101 figures, 13 in colour, and 33 tables, 1997

 

 

 

 

..............................

Developments in Ophthalmology

Library of Congress Cataloging-in-Publication Data

Cicatrising conjunctivitis / volume editors, W. Bernauer, J.K.G. Dart, M.J. Elder; including a foreword by John Forrester.

(Developments in ophthalmology; vol. 28) Includes bibliographical references and index.

1. Conjunctivitis. 2. Cicatrices. I. Bernauer, W. (Wolfgang) II. Dart, J.K.G. (John K.G.) III. Elder, M.J. (Mark J.) IV. Series.

[DNLM: 1. Conjunctivitis – physiopathology. 2. Conjunctiva – physiopathology. W1 DE998NG v.28 1997 / WW 212 C568 1997]

RE321.C53 1997 617.77–dc21

ISBN 3–8055–6443–0 (hardcover: alk. paper)

Bibliographic Indices. This publication is listed in bibliographic services, including Current ContentsÔ and Index Medicus.

Drug Dosage. The authors and the publisher have exerted every eVort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Ó Copyright 1997 by S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland) Printed in Switzerland on acid-free paper by Reinhardt Druck, Basel

ISBN 3–8055–6443–0

..............................

Contents

VIII Contributing Authors

X Foreword

XII Preface

XIV Acknowledgements

1Introduction

1Introduction to Cicatrising Conjunctivitis

Bernauer, W. (Zu¨rich); Elder, M.J. (Christchurch); Dart J.K.G. (London)

2Examples of Temporally Limited Conjunctival Cicatrisation

11Aspects of Trachoma

Daniell, M.D.; Taylor, H.R. (Melbourne)

24Stevens–Johnson Syndrome

Coster, D.J. (Adelaide)

32Membranous, Pseudomembranous and Ligneous Conjunctivitis

De Cock, R. (Canterbury)

3 Chronic Progressive Conjunctival Cicatrisation

3A The Conditions

46Cicatricial Pemphigoid

Bernauer, W. (Zu¨rich); Itin, P.H. (Basel); Kirtschig, G. (Marburg)

64Linear IgA Disease

Wojnarowska, F.; Frith, P. (Oxford)

V

73Mucocutaneous Paraneoplastic Disorders

Itin, P.H.; Bu¨chner, S.A. (Basel); Pittelkow, M.R. (Rochester, Minn.)

86Drug-Induced Conjunctival Cicatrisation

Broadway, D. (Vancouver)

3B The Evaluation of Patients

102 Immunological Investigations

Bernauer, W. (Zu¨rich); Itin, P.H. (Basel)

111Monitoring of Activity and Progression

Elder, M.J. (Christchurch); Bernauer, W. (Zu¨rich)

3C Aetiology and Pathogenesis

123 What Initiates the Immune Response? Possible Mechanisms from the Ophthalmologist’s View

Bernauer, W. (Zu¨rich)

127 Antigen Processing and Presentation

Larkin, D.F.P. (London)

135 The Immunologic Target: Antigenic Aspects of Basement Membranes

Elder, M.J. (Christchurch)

149 The Cellular Response in the Conjunctiva

Bernauer, W. (Zu¨rich)

159 The Role of Cytokines

Elder, M.J. (Christchurch)

3D Sequelae of Chronic Progressive Conjunctival Cicatrisation

176 The Eyelid Sequelae

Elder, M.J. (Christchurch); Collin, R. (London)

182 Keratopathy

Elder, M.J. (Christchurch)

3E Management

192 General Considerations

Elder, M.J. (Christchurch); Bernauer, W. (Zu¨rich); Dart, J.K.G. (London)

196 Topical and Systemic Immunosuppression

Elder, M.J.; (Christchurch)

207Lid Surgery

Elder, M.J. (Christchurch); Collin, R. (London)

219 The Management of Ocular Surface Disease

Elder, M.J. (Christchurch); Bernauer, W. (Zu¨rich); Dart, J.K.G. (London)

Contents

VI

228Corneal and Cataract Surgery

MacLeod, J.D.A.; Dart, J.K.G.; Gray, T.B. (London)

240Management of Glaucoma

Broadway, D. (Vancouver)

4 New Therapeutic Concepts

242New Concepts: Manipulation of the Wound-Healing Response

Cordeiro, M.F.; Occleston, N.L.; Khaw, P.T. (London)

261 Subject Index

Contents

VII

..............................

Contributing Authors

Wolfgang Bernauer, MD

Wound Healing Group and

Department of Ophthalmology

Glaucoma Unit

University of Zu¨rich

Institute of Ophthalmology and

Frauenklinikstrasse 24

Moorfields Eye Hospital

CH–8091 Zu¨rich (Switzerland)

London EC1V 9EL (UK)

David Broadway, MD, FRCOphth

Douglas J. Coster, FRCS

Department of Ophthalmology

Professor of Ophthalmology

University of British Columbia

Department of Ophthalmology

2550 Willow Street

Flinders Medical Centre

Vancouver, British Columbia

Bedford Park, South Australia 5042

V5Z 3N9 (Canada)

(Australia)

Stanislav A. Bu¨chner, MD

Mark D. Daniell, MBBS, MS,

Department of Dermatology

FRACO, FRACS

University of Basel

Consultant Ophthalmologist

Kantonsspital

Corneal Unit

Petersgraben 4

Royal Victorian Eye and Ear

CH–4031 Basel (Switzerland)

Hospital

 

Melbourne 3000 (Australia)

Richard Collin, FRCS

 

Consultant Ophthalmologist

John K.G. Dart, DM, FRCOphth

Moorfields Eye Hospital

Consultant Ophthalmologist

City Road

Moorfields Eye Hospital

London EC1V 2PD (UK)

City Road

 

London EC1V 2PD (UK)

Francesca Cordeiro, MRCP,

 

FRCOphth

Romain De Cock, FRCS, FRCOphth

Wellcome Trust Vision Research

Consultant Ophthalmologist

Fellow

Kent & Canterbury NHS Trust

Formerly Guide Dogs for the Blind

Ethelbert Road

Fellow

Canterbury CT1 3NG (UK)

VIII

Mark J. Elder, MD, FRACS, FRACO

Consultant Ophthalmologist

Ophthalmology Department

Christchurch Hospital

PO Box 4710

Christchurch (New Zealand)

John V. Forrester, MD, FRCS(E)

Cockburn Professor of

Ophthalmology

University of Aberdeen

and Aberdeen Royal Infirmary

Aberdeen AB25 2ZD (UK)

Peggy Frith, MA, FRCP

Consultant Medical Ophthalmologist

Oxford Eye Hospital

Oxford OX2 6AW (UK)

Trevor B. Gray, FRACO, FRACS

Moorfields Eye Hospital

City Road

London EC1V 2PD (UK)

Peter H. Itin, MD

Department of Dermatology

University of Basel

Kantonsspital

Petersgraben 4

CH–4031 Basel (Switzerland)

P.T. Khaw, MRCP, FRCS,

FRCOphth, PhD

Consultant Ophthalmologist

Director, Wound Healing Group and

Glaucoma Unit

Institute of Ophthalmology and

Moorfields Eye Hospital

London EC1V 9EL (UK)

Gudula Kirtschig, MD

Department of Dermatology

University of Marburg

D-35037 Marburg (Germany)

Frank Larkin, MD, MRCPI, FRCS,

FRCOphth

Moorfields Eye Hospital

City Road

London EC1V 2PD (UK)

J.D.A. MacLeod, MA, FRCOpth

Moorfields Eye Hospital

City Road

London EC1V 2PD (UK)

N.L. Occleston, BSc, MPhil, PhD

International Glaucoma Association

Research Scientist

Wound Healing Group and

Glaucoma Unit

Institute of Ophthalmology and

Moorfields Eye Hospital

London EC1V 9EL (UK)

Mark R. Pittelkow, MD

Department of Dermatology

Mayo Clinic

200 First Street SW

Rochester, MN 55905 (USA)

Hugh R. Taylor, MD, FRACO,

FRACS

Professor of Ophthalmology

Department of Ophthalmology

University of Melbourne

Royal Victorian Eye and Ear

Hospital

Melbourne 3000 (Australia)

Fenella Wojnarowska, MSc, DM,

FRCP

Reader in Dermatology and

Consultant Dermatologist

Oxford RadcliVe Hospital

Old Road

Headington, Oxford OX3 7LJ

(UK)

Contributing Authors

IX

..............................

Foreword

In this book Wolfgang Bernauer, John Dart and Mark Elder synthesise our current state of knowledge in disorders causing cicatrisation of the conjunctiva. For many years now there has been a gap in the ophthalmic literature with regard to this field, and this volume, in a very timely fashion, fills this need exactly.

Cicatrising conjunctival disease can occur in many conditions and for the jobbing ophthalmologist the diagnosis, but especially the treatment, can be daunting. Most of us throw up our hands in despair when faced with such a case and are only too glad to refer these very diYcult problems to specialists in the field.

These three authors undoubtedly have a wide experience in the field and inherited much of it from the work of Peter Wright who set up a pioneering tertiary referral clinic at Moorfields Eye Hospital to deal with these special problems.

The book addresses all aspects of the disease from its clinical manifestation through the path of physiology and immunopathology to current management approaches. Newer knowledge in the field of immunology allows us ever increasing insight into the mechanisms of the disease and more and more targets of auto-immune attack are being identified. However, it is likely that from a treatment point of view knowledge of the cells that cause the damage are likely to provide pointers to future therapies. The notion indeed that an exaggerated T cell response with its associated fibrosis may underly the pathogenesis of some cases of cicatrisation is indeed intriguing and quite plausible. The information on fibrosis and fibrotic mechanisms is therefore very appropriately placed in this text.

Contributing Authors

X

The medical and surgical management of cicatrising conjunctival disease is of course extremely diYcult. The latter sections of the book address the investigation and management of these conditions and point the way forward to new approaches. There is little doubt that this succinct and excellent volume should provide the bench mark for future studies in this field and should encourage interested ophthalmologists to take up the challenge of how to deal with these problems. For the sake of our patients we have no option.

Prof. John Forrester, Aberdeen

Foreword

XI